RecruitingNCT06588452

Manual Versus AI-Assisted Clinical Trial Screening Using Large-Language Models


Sponsor

Brigham and Women's Hospital

Enrollment

4,500 participants

Start Date

Mar 4, 2024

Study Type

OBSERVATIONAL

Conditions

Summary

A prospective randomized controlled trial comparing manual review and AI screening for patient eligibility determination and enrollments. A structured query will identify potentially eligible patients from the Mass General Brigham Electronic Data Warehouse (EDW), who will then be randomized into either the manual review arm or the AI-assisted review arm.


Eligibility

Min Age: 18 YearsMax Age: 90 Years

Plain Language Summary

Simplified for easier understanding

This study is comparing whether an AI tool can screen patients with heart failure for clinical trial eligibility just as well as doctors doing it manually. It is not testing a new treatment — it is studying the AI screening process itself using existing patient records from a large hospital network. **You may be eligible if...** - You have a documented diagnosis of heart failure - You had your heart pumping function (ejection fraction) measured within the past 2 years - You have been seen by a Mass General Brigham provider within the last 2 years **You may NOT be eligible if...** - You have a reduced ejection fraction (below 50%) and are already on or cannot tolerate maximum doses of standard heart failure medications - You have a preserved ejection fraction (above 50%) and are already on or cannot tolerate SGLT2 inhibitors - Your last recorded blood pressure was below 90 mmHg (very low) Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERRECTIFIER - a generative artificial intelligence screening tool

RECTIFIER is a large-language model based, generative artificial intelligence-enabled inclusion and exclusion criteria assessment tool.

OTHERManual clinical trial screening by study staff

The current gold standard - study staff manually review potentially eligible patients through chart review.


Locations(1)

Brigham and Women's Hospital

Boston, Massachusetts, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06588452